Relationship Between Potential Predictors and Mortality in COVID-19 Patients ın Turkey

NCT04789460 | Completed

• 1 other identifier: TURKEYPROMOD
• Study Type: observational
• Target: 816
• Locations: 1 country
• Sites: 1

Brief Summary

In this study, the investigators planned to examine the laboratory characteristics of patients hospitalized with the diagnosis of Covid-19 and to investigate their relationship with mortality.

Conditions

Covid19

Keywords

covid19; ldh; ferritin; mortality; d-dimer

Outcome Measures

Primary Outcomes (1)

• mortality rate

  up to 30 days after discharge

  up to 30 days

Secondary Outcomes (2)

• need for intensive care unit rate

  up to 30 days

• length stay in hospital

  up to 30 days

Study Arms (1)

COVID-19 patients in hospital

All patients aged 18 years and over, positive for SARS-CoV-2 PCR test and / or Covid-19 treatment with signs of Covid-19 disease on CT in two tertier hospital in Istanbul

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients hospitalized with the diagnosis of covid-19

You may qualify if:

• All patients who are 18 years of age and older, positive for SARS-CoV-2 PCR test and / or Covid-19 disease findings on CT will be included in the study.

You may not qualify if:

• Patients with negative SARS-CoV-2 PCR test, pneumonia on CT but not given Covid-19 treatment by not considering Covid-19 by their doctor will not be included.

Sponsors & Collaborators

• Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey: lead

Study Sites (1)

SBU Sultan Abdulhamid Han

Istanbul, Asia, 34668, Turkey (Türkiye)

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Elif Yıldırım Ayaz, M.D.

  Sultan Abdülhamid Han Training and Rsearch Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 4, 2021
• First Posted: March 9, 2021
• Study Start: March 5, 2021
• Primary Completion: March 28, 2021
• Study Completion: March 28, 2021
• Last Updated: May 24, 2021

Record last verified: 2021-05

Locations

TU (1)